Zydelig®

Active substance Idelalisib
Holder Cromsource on behalf of Gilead Sciences Benelux
Status Closed
Indication Relapsed chronic lymphocytic leukemia in adult patients who cannot be treated with chemotherapy due to refractoriness or comorbidities
Public documents Approbation
Information for the patient
Informed consent
Last update 17/07/2015
Last updated on